TRIO Awarded NATALEE Study, Largest Single Phase III Breast Cancer Clinical Trial in its History! 

Ribociclib Combination Therapy in Adjuvent Setting Represents A Promising Therapy Against Breast Cancer.  Read more in the Press Release from Globe News.

 

TRIO-US & UCLA 23rd Annual Research Conference September 7-9, 2018!

This years conference is taking place September 7-9, 2018!  If you have not received an invitation and are interested in attending the conference or wish to make a monetary donation to support the Research Conference please contact Allison Muff @ mallison@mednet.ucla.edu